Edition:
India

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

82.70EUR
22 Nov 2017
Change (% chg)

€-0.88 (-1.05%)
Prev Close
€83.58
Open
€83.76
Day's High
€83.76
Day's Low
€82.70
Volume
439,251
Avg. Vol
545,378
52-wk High
€89.22
52-wk Low
€71.49

Latest Key Developments (Source: Significant Developments)

FMC Q3 impacted by natural disasters in North America
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - FMC AG :‍Says Q3 sales up 3 pct at ‍4.336​ billion eur (+8 pct at constant currency).Says Q3 EBIT flat at ‍609​ million eur (+4 pct at constant currency).Says Q3 net income up 2 pct at ‍309 ​million eur.Says North American business impacted by natural disasters.Says ‍excluding effects from natural disasters, effects of agreement with U.S. Departments of Veterans Affairs and Justice, confirms its full-year outlook 2017​​.Says North America Care Coordination activities grow by 20% (+26 pct at constant currency), margin expands significantly to 7 pct​.Says ‍closing of NxStage deal is currently expected to occur in 2018​.Reuters poll average for FMC q3 net revenue was 4.41 billion eur, EBIT 611 million eur, net income 297 million eur.  Full Article

Germany's FMC buys Indian dialysis group Sandor Nephro
Friday, 2 Sep 2016 

Fresenius Medical Care : Says acquires dialysis service provider Sandor Nephro services in India, which is expected to generate around $3 mln in 2016 revenues . Says to acquire 85 pct of equity interest in Indian dialysis group Sandor Nephro services from a group of investors .Expects investment to be accretive in 2017 on earnings after tax..  Full Article

FMC sticks to guidance after Q2 results
Tuesday, 2 Aug 2016 

Fresenius Medical Care AG : Says q2 ebit $641 million . Says q2 net income $294 million . Says q2 sales $4,420 million . Reuters poll average for fmc q2 net revenue was $4.44 billion, ebit $634 million, net income $284 million .Says despite unfavorable foreign currency developments and continuous cost pressure, we are confident we will achieve our full year guidance.  Full Article

Fresenius Medical Care AG & Co KGaA confirms FY 2016 outlook
Tuesday, 3 May 2016 

Fresenius Medical Care AG & Co KGaA:Based on the positive Q1 business development, confirms outlook for FY 2016.Expects a currency-adjusted revenue growth between 7 percent and 10 percent for FY2016; net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA is expected to increase by 15 percent to 20 percent over the previous year.  Full Article

Fresenius Medical Care comments on FY 2016 outlook; to propose dividend
Wednesday, 24 Feb 2016 

Fresenius Medical Care AG & Co KGaA:Shareholders will be asked to approve a dividend of 0.80 euros per share, increase of 3 pct compared to 2014.Based on projection Fresenius Medical Care provided for FY 2016, company is guiding for revenue to grow 7-10 pct at constant currency excluding acquisitions 2015 and 2016.Net income attributable to shareholders of Fresenius Medical Care is expected to increase by 15-20 pct in FY 2016 excluding acquisitions in 2015 and 2016.  Full Article

Fresenius Medical Care AG & Co KGaA reaches agreement in principle to resolve the GranuFlo/NaturaLyte product liability litigation
Thursday, 18 Feb 2016 

Fresenius Medical Care AG & Co KGaA:Fresenius Medical Care North America has reached an agreement in principle with committee designated by plaintiffs to resolve litigation in United States involving GranuFlo/NaturaLyte.Settlement amount would be $250 million, provided that 97 pct of all plaintiffs agree to the settlement by July 2016 with the funding provided in August 2016.Company expects a pre-tax charge of $60 million from settlement and other costs to finalize this matter.  Full Article

Fresenius Medical Care AG & Co KGaA announces changes in management board
Thursday, 28 Jan 2016 

Fresenius Medical Care AG & Co KGaA:Roberto Fusté to resign from his operational responsibilities and Management Board position effective March 31.Harry de Wit to succeed Roberto Fusté as the CEO and Management Board member for the region.  Full Article

Fresenius adj EBIT up 11 pct on hospitals, drugs

FRANKFURT, Nov 2 German healthcare group Fresenius said third-quarter adjusted net income gained 11 percent on higher drug sales and helped by the addition of Spanish hospitals chain Quironsalud.